|
SNX27 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.32629999982647E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.32390000073812E-08 |
| Normal-vs-Stage2 |
4.34310000000382E-05 |
| Normal-vs-Stage3 |
1.522640E-01 |
| Normal-vs-Stage4 |
3.237500E-04 |
| Stage1-vs-Stage2 |
3.465000E-01 |
| Stage1-vs-Stage3 |
3.586000E-02 |
| Stage1-vs-Stage4 |
9.812800E-01 |
| Stage2-vs-Stage3 |
1.334000E-01 |
| Stage2-vs-Stage4 |
5.236000E-01 |
| Stage3-vs-Stage4 |
1.825180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.78129999534238E-08 |
| Normal-vs-AfricanAmerican |
6.11400000000151E-05 |
| Normal-vs-Asian |
2.554400E-01 |
| Caucasian-vs-AfricanAmerican |
9.806800E-01 |
| Caucasian-vs-Asian |
6.727200E-01 |
| AfricanAmerican-vs-Asian |
7.933800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.37669883773606E-11 |
| Normal-vs-Female |
1.190290E-02 |
| Male-vs-Female |
7.884100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.567900E-02 |
| Normal-vs-Extreme_Weight |
3.30789950986343E-10 |
| Normal-vs-Obese |
9.78990000000124E-05 |
| Normal-vs-Extreme_Obese |
1.391730E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.512200E-02 |
| Normal_Weight-vs-Obese |
6.949000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.748000E-01 |
| Extreme_Weight-vs-Obese |
5.176900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.337580E-02 |
| Obese-vs-Extreme_Obese |
7.358000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.179400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.82869999999702E-05 |
| Normal-vs-Age(61-80Yrs) |
4.40349978703125E-11 |
| Normal-vs-Age(81-100Yrs) |
4.394200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.997600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.133580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.408400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.527900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.930000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.385800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62592161956354E-12 |
| Normal-VS-Type2 PRCC |
5.800000E-02 |
| Normal-VS-KIRP CIMP |
5.169400E-04 |
| Normal-VS-Unclassified PRCC |
1.462380E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.763100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.912800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.717400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.016200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.607400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.302000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.47670000000211E-05 |
| Normal-vs-N1 |
3.084100E-02 |
| Normal-vs-N2 |
1.596210E-01 |
| N0-vs-N1 |
1.658400E-01 |
| N0-vs-N2 |
6.000800E-01 |
| N1-vs-N2 |
8.919800E-01 |
|
|
